PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells

Age-related clonal hematopoiesis associated with adverse outcomes

Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841 · see citing works

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D. B., Sougnez, C. L., Gabriel, S., Meyerson, M. M., Lander, E. S., & Getz, G. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,838 · see citing works

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637 · see citing works

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531 · see citing works

CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling

Platt, R. J., Chen, S., Zhou, Y., Yim, M. J., Swiech, L., Kempton, H. R., Dahlman, J. E., Parnas, O., Eisenhaure, T. M., Jovanovic, M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.014 · Cited by 2,001 · see citing works

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971 · see citing works

Age-related mutations associated with clonal hematopoietic expansion and malignancies

Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874 · see citing works

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

Certo, M. V., Moore, V. D. G., Nishino, M., Wei, G., Korsmeyer, S. J., Armstrong, S. A., & Letai, A. G. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.027 · Cited by 1,278 · see citing works

Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia

Wong, T. N., Ramsingh, G., Young, A. L., Miller, C. A., Touma, W., Welch, J. S., Lamprecht, T. L., Shen, D., Hundal, J., Fulton, R. S., et al. (2015) · Nature · doi:10.1038/nature13968 · Cited by 892 · see citing works

Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes

Coombs, C. C., Zehir, A., Devlin, S. M., Kishtagari, A., Syed, A., Jonsson, P., Hyman, D. M., Solit, D. B., Robson, M. E., Baselga, J., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.07.010 · Cited by 866 · see citing works

Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

Lindsley, R. C., Saber, W., Mar, B. G., Redd, R., Wang, T., Haagenson, M. D., Grauman, P. V., Hu, Z.-H., Spellman, S. R., Lee, S. J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611604 · Cited by 776 · see citing works

Integrated proteomic analysis of post-translational modifications by serial enrichment

Mertins, P., Qiao, J., Patel, J., Udeshi, N. D., Clauser, K. R., Mani, D. R., Burgess, M. W., Gillette, M. A., Jaffe, J. D., & Carr, S. A. (2013) · Nature Methods · doi:10.1038/nmeth.2518 · Cited by 619 · see citing works

Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing

Heckl, D., Kowalczyk, M. S., Yudovich, D., Belizaire, R., Puram, R. V., McConkey, M. E., Thielke, A., Aster, J. C., Regev, A., & Ebert, B. L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2951 · Cited by 555 · see citing works

Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner

Fiscella, M., Zhang, H., Fan, S., Sakaguchi, K., Shen, S., Mercer, W. E., Woude, G. F. V., O'Connor, P. M., & Appella, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6048 · Cited by 527 · see citing works

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma

Gibson, C. J., Lindsley, R. C., Tchekmedyian, V., Mar, B. G., Shi, J., Jaiswal, S., Bosworth, A., Francisco, L., He, J., Bansal, A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.6712 · Cited by 480 · see citing works

Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity

Bulavin, D. V., Demidov, O. N., Saito, S., Kauraniemi, P., Dudgeon, C., Amundson, S. A., Ambrosino, C., Sauter, G., Nebreda, Á. R., Anderson, C. W., et al. (2002) · Nature Genetics · doi:10.1038/ng894 · Cited by 437 · see citing works

Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels

Mertins, P., Yang, F., Liu, T., Mani, D. R., Petyuk, V., Gillette, M. A., Clauser, K. R., Qiao, J., Gritsenko, M. A., Moore, R. J., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.036392 · Cited by 407 · see citing works

Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy

Montero, J., Sarosiek, K. A., DeAngelo, J. D., Maertens, O., Ryan, J., Ercan, D., Piao, H., Horowitz, N. S., Berkowitz, R. S., Matulonis, U., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.042 · Cited by 378 · see citing works

Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer

Ruark, E., Snape, K. M. G., Humburg, P., Loveday, C., Bajrami, I., Brough, R., Rodrigues, D. N., Renwick, A., Seal, S., Ramsay, E., et al. (2012) · Nature · doi:10.1038/nature11725 · Cited by 247 · see citing works

The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways

Lu, X., Nguyen, T., Moon, S.-H., Darlington, Y. F., Sommer, M., & Donehower, L. A. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9127-x · Cited by 244 · see citing works

Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction

Gilmartin, A. G., Faitg, T. H., Richter, M. C., Groy, A., Seefeld, M. A., Darcy, M. G., Peng, X., Federowicz, K., Yang, J., Zhang, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1427 · Cited by 207 · see citing works

Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential

Wong, T. N., Miller, C. A., Jotte, M. R. M., Bagegni, N. A., Baty, J., Schmidt, A. P., Cashen, A. F., Duncavage, E. J., Helton, N., Fiala, M. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02858-0 · Cited by 198 · see citing works

Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint

Kleiblova, P., Shaltiel, I. A., Benada, J., Ševčík, J., Pecháčková, S., Pohlreich, P., Voest, E. E., Dundr, P., Bartek, J., Kleibl, Z., et al. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201210031 · Cited by 170 · see citing works

Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers

Natrajan, R., Lambros, M. B. K., Rodríguez-Pinilla, S. M., Moreno‐Bueno, G., Tan, D. S. P., Marchiò, C., Vatcheva, R., Rayter, S., Mahler-Araujo, B. M., Fulford, L. G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1878 · Cited by 170 · see citing works

PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas

Tan, D. S. P., Lambros, M. B. K., Rayter, S., Natrajan, R., Vatcheva, R., Gao, Q., Marchiò, C., Geyer, F. C., Savage, K., Parry, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2403 · Cited by 165 · see citing works

iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry

Ryan, J. A., Montero, J., Rocco, J. W., & Letai, A. G. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0107 · Cited by 129 · see citing works

Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma

Swisher, E. M., Harrell, M. I., Norquist, B. M., Walsh, T., Brady, M. F., Lee, M. J., Hershberg, R. M., Kalli, K. R., Lankes, H. A., Konnick, E. Q., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.6053 · Cited by 104 · see citing works

WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma

Richter, M. C., Dayaram, T., Gilmartin, A. G., Ganji, G., Pemmasani, S. K., Key, H. V. D., Shohet, J. M., Donehower, L. A., & Kumar, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115635 · Cited by 67 · see citing works

Creation of Novel Protein Variants with CRISPR/Cas9-Mediated Mutagenesis: Turning a Screening By-Product into a Discovery Tool

Donovan, K. F., Hegde, M., Sullender, M. E., Vaimberg, E. W., Johannessen, C. M., Root, D. E., & Doench, J. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170445 · Cited by 57 · see citing works

PPM1DMosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations

Pharoah, P. D. P., Song, H., Dicks, E., Intermaggio, M. P., Harrington, P. A., Baynes, C., Alsop, K., Chenevix‐Trench, G., Bogdanova, N. V., Cicek, M. S., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv347 · Cited by 50 · see citing works

Clonal hematopoiesis in human aging and disease

Jaiswal, S., & Ebert, B. L. (2019) · Science · doi:10.1126/science.aan4673 · Cited by 1,156 · see citing works

Bone marrow niches in haematological malignancies

Méndez‐Ferrer, S., Bonnet, D. A., Steensma, D. P., Hasserjian, R. P., Ghobrial, I. M., Gribben, J. G., Andreeff, M., & Krause, D. S. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0245-2 · Cited by 487 · see citing works

PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy

Hsu, J. I., Dayaram, T., Tovy, A., De Braekeleer, E., Jeong, M., Wang, F., Zhang, J., Heffernan, T. P., Gera, S., Kovacs, J. J., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.10.004 · Cited by 425 · see citing works

Cancer as a disease of old age: changing mutational and microenvironmental landscapes

Laconi, E., Marongiu, F., & DeGregori, J. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0721-1 · Cited by 348 · see citing works

Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling

Hormaechea-Agulla, D., Matatall, K. A., Le, D. T., Kain, B., Long, X., Kus, P., Jaksik, R., Challen, G. A., Kimmel, M., & King, K. Y. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.03.002 · Cited by 329 · see citing works

Life histories of myeloproliferative neoplasms inferred from phylogenies

Williams, N., Lee, J., Mitchell, E., Moore, L., Baxter, E. J., Hewinson, J., Dawson, K. J., Menzies, A., Godfrey, A. L., Green, A. R., et al. (2022) · Nature · doi:10.1038/s41586-021-04312-6 · Cited by 285 · see citing works

Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management

Shimony, S. O., Stahl, M. F., & Stone, R. M. (2025) · American Journal of Hematology · doi:10.1002/ajh.27625 · Cited by 246 · see citing works

Life histories of myeloproliferative neoplasms inferred from phylogenies.

Williams, N., Lee, J., Mitchell, E., Moore, L., Baxter, E. J., Hewinson, J., Dawson, K. J., Menzies, A. H., Godfrey, A. L., Green, A. R., et al. (2022) · RePEc: Research Papers in Economics · doi:10.17863/cam.80309 · Cited by 216 · see citing works

Clonal hematopoiesis and non-hematologic disorders

Jaiswal, S. (2020) · Blood · doi:10.1182/blood.2019000989 · Cited by 182 · see citing works

Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant

Mouhieddine, T. H., Sperling, A. S., Redd, R. A., Park, J., Leventhal, M. J., Gibson, C. J., Manier, S., Nassar, A. H., Capelletti, M., Huynh, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16805-5 · Cited by 171 · see citing works

Cardiovascular Disease, Aging, and Clonal Hematopoiesis

Evans, M. A., Sano, S., & Walsh, K. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032544 · Cited by 163 · see citing works

Lenalidomide promotes the development of TP53 -mutated therapy-related myeloid neoplasms

Sperling, A. S., Guerra, V. A., Kennedy, J. A., Yan, Y., Hsu, J. I., Wang, F., Nguyen, A. T., Miller, P. G., McConkey, M. E., Barrios, V. A. Q., et al. (2022) · Blood · doi:10.1182/blood.2021014956 · Cited by 153 · see citing works

Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients

Zhang, C. R. C., Nix, D., Gregory, M., Ciorba, M. A., Ostrander, E. L., Newberry, R. D., Spencer, D. H., & Challen, G. A. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.11.008 · Cited by 137 · see citing works

The role of ASXL1 in hematopoiesis and myeloid malignancies

Asada, S., Fujino, T., Goyama, S., & Kitamura, T. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03084-7 · Cited by 136 · see citing works

Clonal Hematopoiesis: Mechanisms Driving Dominance of Stem Cell Clones

Challen, G., & Goodell, M. A. (2020) · Blood · doi:10.1182/blood.2020006510 · Cited by 131 · see citing works

Clonal hematopoiesis: Mutation-specific adaptation to environmental change

Florez, M. A., Tran, B. T., Wathan, T. K., DeGregori, J., Pietras, E. M., & King, K. Y. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.05.006 · Cited by 129 · see citing works

Metal-dependent Ser/Thr protein phosphatase PPM family: Evolution, structures, diseases and inhibitors

Kamada, R., Kudoh, F., Ito, S., Tani, I., Janairo, J. I. B., Omichinski, J. G., & Sakaguchi, K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107622 · Cited by 126 · see citing works

Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway

Chen, S., Wang, Q., Yu, H., Capitano, M. L., Vemula, S., Nabinger, S. C., Gao, R., Yao, C., Kobayashi, M., Geng, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13542-2 · Cited by 121 · see citing works

Clonal hematopoiesis, somatic mosaicism, and age-associated disease

Evans, M. A., & Walsh, K. (2022) · Physiological Reviews · doi:10.1152/physrev.00004.2022 · Cited by 105 · see citing works

CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors

Reed, S. C., Croessmann, S., & Park, B. H. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2598 · Cited by 108 · see citing works

CHIP, CCUS, and Other Acronyms: Definition, Implications, and Impact on Practice

Dezern, A. E., Malcovati, L., & Ebert, B. L. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_239083 · Cited by 99 · see citing works

Clonal hematopoiesis and risk for hematologic malignancy

Warren, J. T., & Link, D. C. (2020) · Blood · doi:10.1182/blood.2019000991 · Cited by 98 · see citing works

The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene <i>Ppm1d</i> Promotes Inflammation and Non-Ischemic Heart Failure in Mice

Yura, Y., Miura-Yura, E., Katanasaka, Y., Min, K.-D., Chavkin, N., Polizio, A. H., Ogawa, H., Horitani, K., Doviak, H., Evans, M. A., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.319314 · Cited by 87 · see citing works

Systematic characterization of mutations altering protein degradation in human cancers

Tokheim, C. J., Wang, X., Timms, R. T., Zhang, B., Mena, E. L., Wang, B., Chen, C., Ge, J., Chu, J., Zhang, W., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.01.020 · Cited by 82 · see citing works

Germline risk of clonal haematopoiesis

Silver, A. J., Bick, A. G., & Savona, M. R. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00356-6 · Cited by 80 · see citing works

TP53-mediated therapy-related clonal hematopoiesis contributes to doxorubicin-induced cardiomyopathy by augmenting a neutrophil-mediated cytotoxic response

Sano, S., Wang, Y., Ogawa, H., Horitani, K., Sano, M., Polizio, A. H., Kour, A., Yura, Y., Doviak, H., & Walsh, K. (2021) · JCI Insight · doi:10.1172/jci.insight.146076 · Cited by 82 · see citing works

Clonal hematopoiesis and inflammation – the perpetual cycle

Avagyan, S., & Zon, L. I. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.12.001 · Cited by 79 · see citing works

Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer

Arguelles, O. C., Jaiswal, S., Shlush, L. I., Moslehi, J. J., Schimmer, A. D., Barac, A., & Thavendiranathan, P. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0302 · Cited by 72 · see citing works

Environmental influences on clonal hematopoiesis

King, K. Y., Huang, Y., Nakada, D., & Goodell, M. A. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.005 · Cited by 74 · see citing works

Ion Channels: New Actors Playing in Chemotherapeutic Resistance

Kischel, P., Girault, A., Rodat‐Despoix, L., Chamlali, M., Radoslavova, S., Daya, H. A., Lefebvre, T., Foulon, A., Rybarczyk, P., Hague, F., et al. (2019) · Cancers · doi:10.3390/cancers11030376 · Cited by 72 · see citing works

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses

Knudsen, T. A., Skov, V., Stevenson, K. E., Werner, L. L., Duke, W., Laurore, C., Gibson, C. J., Nag, A., Thorner, A. R., Wollison, B. M., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004856 · Cited by 71 · see citing works

The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms

Schwartz, J. R., Ma, J., Kamens, J. L., Westover, T., Walsh, M. P., Brady, S. W., Michael, J. R., Chen, X., Montefiori, L. E., Song, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21255-8 · Cited by 68 · see citing works

Clonal Hematopoiesis and Its Impact on Human Health

Ahmad, H., Jahn, N., & Jaiswal, S. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-112347 · Cited by 66 · see citing works

Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes

Nagata, Y., Makishima, H., Kerr, C. M., Przychodzen, B. P., Aly, M. M., Goyal, A., Awada, H. K., Asad, M., Kuzmanovic, T., Suzuki, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13001-y · Cited by 65 · see citing works

Clonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure

Yura, Y., Sano, S., & Walsh, K. X. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.08.006 · Cited by 67 · see citing works

NPM1 ‐mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions

Falini, B. (2023) · American Journal of Hematology · doi:10.1002/ajh.26989 · Cited by 63 · see citing works

ASXL1 mutation in clonal hematopoiesis

Fujino, T., & Kitamura, T. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.002 · Cited by 61 · see citing works

The Molecular Genetics of Myeloproliferative NeoplasmsPreprint

Marneth, A. E., & Mullally, A. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034876 · Cited by 62 · see citing works

Hallmarks of stem cell aging

Rando, T. A., Brunet, A., & Goodell, M. A. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.06.004 · Cited by 66 · see citing works

Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia

Falini, B., & Martelli, M. P. (2023) · American Journal of Hematology · doi:10.1002/ajh.26812 · Cited by 61 · see citing works

Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences

Burren, O. S., Dhindsa, R. S., Deevi, S. V. V., Wen, S., Nag, A., Mitchell, J., Hu, F., Loesch, D. P., Smith, K. R., Razdan, N., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01884-7 · Cited by 57 · see citing works

Somatic mutation and selection at population scale

Lawson, A. R. J., Abascal, F., Nicola, P. A., Lensing, S. V., Roberts, A. L., Kalantzis, G., Baez‐Ortega, A., Brzozowska, N., Moustafa, J. S. E.-S., Vaitkute, D., et al. (2025) · Nature · doi:10.1038/s41586-025-09584-w · Cited by 72 · see citing works

Clonal Hematopoiesis: From Mechanisms to Clinical Intervention

Köhnke, T., & Majeti, R. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0901 · Cited by 59 · see citing works

Chronic interleukin-1 exposure triggers selection for <i>Cebpa</i> -knockout multipotent hematopoietic progenitors

Higa, K. C., Goodspeed, A., Chavez, J. S., De Dominici, M., Danis, E., Zaberezhnyy, V., Rabe, J. L., Tenen, D. G., Pietras, E. M., & DeGregori, J. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20200560 · Cited by 57 · see citing works

PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation

Khadka, P., Reitman, Z. J., Lu, S. D., Buchan, G. B. J., Gionet, G. L., Dubois, F. P. B., Carvalho, D. M., Shih, J., Zhang, S., Greenwald, N. F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28198-8 · Cited by 55 · see citing works

Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post–autologous stem cell transplantation

Soerensen, J. F., Aggerholm, A., Kerndrup, G. B., Hansen, M. H., Ewald, I. K. L., Bill, M., Ebbesen, L. H., Rosenberg, C. A., Hokland, P., Ludvigsen, M., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001157 · Cited by 51 · see citing works

PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy

Miller, P. G., Sperling, A. S., Mayerhofer, C., McConkey, M. E., Ellegast, J. M., Silva, C. D., Cohen, D. N., Wang, C., Sharda, A., Yan, N., et al. (2023) · Blood · doi:10.1182/blood.2023020331 · Cited by 50 · see citing works

Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia

Higgins, A. S., & Shah, M. V. (2020) · Genes · doi:10.3390/genes11070749 · Cited by 50 · see citing works

Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data

Loscocco, G. G., Guglielmelli, P., & Vannucchi, A. M. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s287944 · Cited by 49 · see citing works

Clonal Hematopoiesis and Its Impact on Cardiovascular Disease

Sano, S., Wang, Y., & Walsh, K. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0871 · Cited by 46 · see citing works

Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma

Akamandisa, M. P., Nie, K., Nahta, R., Hambardzumyan, D., & Castellino, R. C. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz053 · Cited by 46 · see citing works

Clonal hematopoiesis and its emerging effects on cellular therapies

Bonin, M. V., Jambor, H. K., Teipel, R., Stölzel, F., Thiede, C., Damm, F., Kroschinsky, F., Schetelig, J., Chavakis, T., & Bornhäuser, M. (2021) · Leukemia · doi:10.1038/s41375-021-01337-8 · Cited by 46 · see citing works

Overlapping features of therapy-related and de novo NPM1 -mutated AML

Othman, J., Meggendorfer, M., Tiacci, E., Thiede, C., Schlenk, R. F., Dillon, R. J., Stasik, S., Venanzi, A., Bertoli, S., Delabesse, É., et al. (2022) · Blood · doi:10.1182/blood.2022018108 · Cited by 43 · see citing works

CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1

Belizaire, R., Koochaki, S., Udeshi, N. D., Vedder, A., Sun, L., Svinkina, T., Hartigan, C. R., McConkey, M. E., Kovalcik, V., Bizuayehu, A., et al. (2021) · Blood · doi:10.1182/blood.2020006528 · Cited by 48 · see citing works

Mechanisms involved in hematopoietic stem cell aging

Fujino, T., Asada, S., Goyama, S., & Kitamura, T. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04356-5 · Cited by 45 · see citing works

Fitness Landscape of Clonal Hematopoiesis Under Selective Pressure of Immune Checkpoint Blockade

Miller, P. G., Gibson, C. J., Mehta, A., Sperling, A. S., Frederick, D. T., Manos, M. P., Miao, B., Hacohen, N., Hodi, F. S., Boland, G. M., et al. (2020) · JCO Precision Oncology · doi:10.1200/po.20.00186 · Cited by 48 · see citing works

Mechanisms of leukemic transformation in congenital neutropenia

Link, D. C. (2018) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000479 · Cited by 44 · see citing works

Clonal hematopoiesis: Pre-cancer PLUS

Silver, A. J., & Jaiswal, S. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2018.12.003 · Cited by 44 · see citing works

Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL

Eskelund, C. W., Husby, S., Favero, F., Klausen, T. W., Rodríguez-González, F. G., Kolstad, A., Pedersen, L. B., Räty, R., Geisler, C. H., Jerkeman, M., et al. (2020) · Blood · doi:10.1182/blood.2019003539 · Cited by 44 · see citing works

Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View

Sikking, M. A., Stroeks, S. L. V. M., Waring, O. J., Henkens, M. T. H. M., Riksen, N. P., Hoischen, A., Heymans, S. R. B., & Verdonschot, J. A. J. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030603 · Cited by 41 · see citing works

Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer

Arends, C. M., Kopp, K., Hablesreiter, R., Estrada, N., Christen, F., Moll, U. M., Zeillinger, R., Schmitt, W., Sehouli, J., Kulbe, H., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02253-3 · Cited by 39 · see citing works

Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state

Miller, P. G., Sathappa, M., Moroco, J. A., Jiang, W., Qian, Y., Iqbal, S., Guo, Q., Giacomelli, A. O., Shaw, S., Vernier, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30463-9 · Cited by 36 · see citing works

Clonal Hematopoiesis–Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer

Weber‐Lassalle, K., Ernst, C., Reuß, A., Möllenhoff, K., Baumann, K., Jackisch, C., Hauke, J., Dietrich, D., Borde, J., Park‐Simon, T., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab231 · Cited by 38 · see citing works

Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism

Castelli, G., Pelosi, E., & Testa, U. (2019) · Cancers · doi:10.3390/cancers11020260 · Cited by 38 · see citing works

Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses

Uyanik, B., Goloudina, A. R., Akbarali, A., Grigorash, B. B., Petukhov, A., Singhal, S. K., Eruslanov, E. B., Chaloyard, J., Lagorgette, L., Hadi, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23330-6 · Cited by 37 · see citing works

Criteria for Diagnosis and Molecular Monitoring of NPM1-Mutated AML

Falini, B., & Dillon, R. J. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-23-0144 · Cited by 36 · see citing works

From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?

Bewersdorf, J. P., Ardasheva, A., Podoltsev, N. A., Singh, A., Biancon, G., Halene, S., & Zeidan, A. M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100587 · Cited by 36 · see citing works

Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma Cells to the PARP Inhibitor Olaparib

Wang, Z., Xu, C., Diplas, B. H., Moure, C. J., Chen, C.-P. J., Chen, L. H., Du, C., Zhu, H., Greer, P. K., Zhang, L., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0507 · Cited by 36 · see citing works

A Broad Overview of Signaling in Ph-Negative Classic Myeloproliferative Neoplasms

Guijarro-Hernández, A., & Vizmanos, J. L. (2021) · Cancers · doi:10.3390/cancers13050984 · Cited by 36 · see citing works

Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy

Mayerhofer, C., Sedrak, M. S., Hopkins, J. O., Li, T., Tayob, N., Faggen, M. G., Sinclair, N. F., Chen, W. Y., Parsons, H. A., Mayer, E. L., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad065 · Cited by 35 · see citing works

Investigation of cancer drug resistance mechanisms by phosphoproteomics

Boulos, J. C., Idres, M. R. Y., & Efferth, T. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105091 · Cited by 34 · see citing works

Aging and Clonal Behavior of Hematopoietic Stem Cells

Yamashita, M., & Iwama, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041948 · Cited by 34 · see citing works

Clonal Hematopoiesis and risk of Acute Myeloid Leukemia

Desai, P. M., Hassane, D. C., & Roboz, G. J. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.05.007 · Cited by 33 · see citing works

Clonal Hematopoiesis: Updates and Implications at the Solid Tumor-Immune Interface

Buttigieg, M. M., & Rauh, M. J. (2023) · JCO Precision Oncology · doi:10.1200/po.23.00132 · Cited by 29 · see citing works

Inflammageing and clonal haematopoiesis interplay and their impact on human disease

Hajishengallis, G., & Chavakis, T. (2026) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00936-y · Cited by 36 · see citing works

Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?

Broxmeyer, H. E., Liu, Y., Kapur, R., Orschell, C. M., Aljoufi, A., Ropa, J. P., Trinh, T. L. P., Burns, S. S., & Capitano, M. L. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10065-y · Cited by 30 · see citing works

Chlorin e6 mediated photodynamic therapy triggers resistance through ATM-related DNA damage response in lung cancer cells

Ma, Q., Shen, M.-O., Han, N., Xu, H., Peng, X., Li, Q., Yu, T., Li, L., Xu, X. M., Liu, B., et al. (2021) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2021.102645 · Cited by 30 · see citing works

Genetic Background of Polycythemia Vera

Regimbeau, M., Mary, R., Hermetet, F., & Girodon, F. (2022) · Genes · doi:10.3390/genes13040637 · Cited by 32 · see citing works

PPM1D suppresses p53-dependent transactivation and cell death by inhibiting the Integrated Stress Response

Andrysík, Z., Sullivan, K. D., Kieft, J. S., & Espinosa, J. M. (2022) · Nature Communications · doi:10.1038/s41467-022-35089-5 · Cited by 31 · see citing works

Ppm1d truncating mutations promote the development of genotoxic stress-induced AML

Burócziová, M., Daněk, P., Oravetzova, A., Chalupova, Z., Alberich-Jordà, M., & Macůrek, L. (2023) · Leukemia · doi:10.1038/s41375-023-02030-8 · Cited by 29 · see citing works

Implications of Clonal Hematopoiesis for Precision Oncology

Miller, P. G., & Steensma, D. P. (2020) · JCO Precision Oncology · doi:10.1200/po.20.00144 · Cited by 29 · see citing works

Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms

Kjær, L. (2020) · Cancers · doi:10.3390/cancers12082100 · Cited by 28 · see citing works

Murine models of clonal haematopoiesis to assess mechanisms of cardiovascular disease

Wang, Y., Sano, S., Ogawa, H., Horitani, K., Evans, M. A., Yura, Y., Miura‐Yura, E., Doviak, H., & Walsh, K. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab215 · Cited by 26 · see citing works

Distinct landscape and clinical implications of therapy-related clonal hematopoiesis

Takahashi, K., Nakada, D., & Goodell, M. A. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180069 · Cited by 28 · see citing works

Clonal Hematopoiesis and therapy related MDS/AML

Desai, P. M., & Roboz, G. J. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.02.006 · Cited by 27 · see citing works

PPM1D in Solid and Hematologic Malignancies: Friend and Foe?

Zhang, L., Hsu, J. I., & Goodell, M. A. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-1018 · Cited by 27 · see citing works

Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma

Lackraj, T., Barouch, S. B., Medeiros, J. J. F., Pedersen, S., Danesh, A., Bakhtiari, M., Hong, M., Tong, K. I., Joynt, J., Arruda, A., et al. (2022) · American Journal of Hematology · doi:10.1002/ajh.26726 · Cited by 26 · see citing works

p53 involvement in clonal hematopoiesis of indeterminate potential

Chen, S., & Liu, Y. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000509 · Cited by 24 · see citing works

PPM1D Is a Therapeutic Target in Childhood Neural Tumors

Milosevic, J., Treis, D., Fransson, S. M., Gallo-Oller, G., Sveinbjørnsson, B., Eißler, N., Tanino, K., Sakaguchi, K., Martinsson, T., Wickström, M., et al. (2021) · Cancers · doi:10.3390/cancers13236042 · Cited by 23 · see citing works

SRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulation

Chen, C.-W., Zhang, L., Dutta, R. K., Niroula, A., Miller, P. G., Gibson, C. J., Bick, A. G., Reyes, J. M., Lee, Y.-T., Tovy, A., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.09.011 · Cited by 24 · see citing works

Evolutionary trajectory of leukemic clones and its clinical implications

Tuval, A., & Shlush, L. I. (2019) · Haematologica · doi:10.3324/haematol.2018.195289 · Cited by 26 · see citing works

Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon

Burócziová, M., Burdová, K., Martinikova, A. S., Kašpárek, P., Kleiblová, P., Danielsen, S. A., Borecká, M., Jeníková, G., Janečková, L., Pavel, J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2057-4 · Cited by 23 · see citing works

Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications

Morsia, E., Torre, E., Poloni, A., Olivieri, A., & Rupoli, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094573 · Cited by 26 · see citing works

Clonal hematopoiesis with DNMT3A and PPM1D mutations impairs regeneration in autologous stem cell transplant recipients

Stelmach, P., Richter, S., Sauer, S., Fabre, M. A., Gu, M., Rohde, C., Janssen, M., Liebers, N., Proynova, R., Weinhold, N., et al. (2023) · Haematologica · doi:10.3324/haematol.2023.282992 · Cited by 22 · see citing works

Clonal Hematopoiesis Has Prognostic Value in Dilated Cardiomyopathy Independent of Age and Clone Size

Sikking, M. A., Stroeks, S. L. V. M., Henkens, M. T. H. M., Raafs, A. G., Cossins, B., van Deuren, R. C., Steehouwer, M., Riksen, N. P., van den Wijngaard, A., Brunner, H. G., et al. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.06.037 · Cited by 23 · see citing works

CHIP: a clonal odyssey of the bone marrow niche

Schleicher, W. E., Hoag, B., Dominici, M. D., DeGregori, J. V., & Pietras, E. M. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180068 · Cited by 23 · see citing works

Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice

Lee, J., Godfrey, A. L., & Nangalia, J. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100708 · Cited by 21 · see citing works

Protein phosphatase, Mg2+/Mn2+‐dependent 1D (PPM1D) mutations in haematological cancer

Husby, S., Justesen, E. H., & Grønbæk, K. (2020) · British Journal of Haematology · doi:10.1111/bjh.17120 · Cited by 21 · see citing works

Somatic Mosaicism in Biology and Disease

Ogawa, H., Horitani, K., Izumiya, Y., & Sano, S. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-061121-040048 · Cited by 20 · see citing works

Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities

Coltro, G., Loscocco, G. G., & Vannucchi, A. M. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.09.001 · Cited by 21 · see citing works

PPM1D Truncating Mutations Confer Chemotherapy Resistance in Hematopoietic Stem Cells, Which Is Reversible By PPM1D Inhibition

Kahn, J. D., Silver, A. J., Mertins, P., Carr, S. A., Jaiswal, S., & Ebert, B. L. (2016) · Blood · doi:10.1182/blood.v128.22.740.740

Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy

Kim, B., Won, D., Lee, S., & Choi, J. R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217521 · Cited by 10 · see citing works

High Prevalence of PPM1D Mutations in Therapy-Related AML/MDS Is Due to Context-Specific Clonal Hematopoiesis

Hsu, J. I., Dayaram, T., Tovy, A., Braekeleer, E. D., Jeong, M., Rogers, J. H., Wang, F., Zhang, J., Garcia‐Manero, G., Kantarjian, H. M., et al. (2018) · Blood · doi:10.1182/blood-2018-99-115007

CHIPing out PPM1D-mutant hematopoiesis

Kindler, T. (2018) · Blood · doi:10.1182/blood-2018-07-861716 · Cited by 1 · see citing works

Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients

Zajkowicz, A., Butkiewicz, D., Drosik, A., Giglok, M., Suwiński, R., & Rusin, M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.79 · Cited by 51 · see citing works